S050 Late-Breaking Research: Session 2
DESCRIPTION
Investigators can submit abstracts describing their most recent unpublished results in all aspects of dermatological research. After a competitive review, the top-scoring studies will be invited to discuss their findings in a brief oral presentation. Emphasis will be placed on practice-changing clinical trials, large population-based studies, innovative new transformative technologies, translationally relevant biomarker studies, and basic science research that sheds light on mechanisms of disease, therapy, or adverse events. All topics related to disorders of the skin, hair and nails will be considered.
LEARNING OBJECTIVES
Describe ground-breaking scientific developments in dermatologic research.
Evaluate and apply information from recent investigations to clinical practice.
SCHEDULE
1:00 PM
Efficacy and Safety of Oral Povorcitinib in Patients With Prurigo Nodularis: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Martin Metz
1:10 PM
Efficacy and Safety of Ruxolitinib Cream in Patients With Hidradenitis Suppurativa (Hurley Stage I and II): Results From a Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study
Martina J Porter, MD, FAAD
1:20 PM
Efficacy and Safety of a Highly Selective Oral TYK2/JAK1 Inhibitor, ICP-332, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II, Randomized, Placebo-Controlled Trial
1:30 PM
Efficacy and safety of amlitelimab (an OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 52-week results from a Phase 2b trial (STREAM-AD)
Stephan Weidinger
1:40 PM
Inflammatory skin disease following the use of SGLT2 inhibitors for diabetes mellitus
Allison Holt
1:50 PM
Deceleration in Melanoma Mortality between 1969-2014
David Latoni, MPH
2:00 PM
Efficacy and safety of the IL-17A- and IL-17F-inhibiting Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial
Brian Kirby
2:10 PM
Deuruxolitinib Demonstrates Significant and Continual Improvement in Scalp Hair Regrowth at 68 Weeks of Dosing in Patients With Alopecia Areata: Pooled Efficacy Results From Ongoing Open-Label Extensi
Brett Andrew King, MD, PhD, FAAD
2:20 PM
Efficacy and safety of lebrikizumab in adult and adolescent patients with skin of color and moderate-to-severe atopic dermatitis: An interim analysis of the open-label Phase 3b trial, ADmirable
Jill S. Waibel, MD, FAAD
2:30 PM
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients 2 to 5 Years of Age with Mild to Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial
Lawrence F Eichenfield, MD, FAAD
2:40 PM
Single-cell profiling of alopecia areata highlights differences in activation of immunotherapeutic targets in patients with and without atopy
Helen Y He, MD
2:50 PM
Maintenance of efficacy and safety with nemolizumab at Week 48: Results from two global phase 3 pivotal studies (ARCADIA-1 and ARCADIA-2) in patients with moderate-to-severe atopic dermatitis
Jonathan I. Silverberg, MD, PhD, MPH, FAAD
3:00 PM
Efficacy, Safety and Pharmacokinetics of First 17 Adult and Adolescent Subjects in Maximal Use Portion of Vehicle Controlled ASCEND Trial of Polyethylene Glycol (iPEG™)-Based Topical Isotretinoin 0.0
Christopher Bunick, PhD, MD, FAAD
3:10 PM
Hair regrowth in patients with severe alopecia areata receiving long-term continuous treatment with baricitinib 4 mg up to Week 76
Rodney Daniel Sinclair, MD, IFAAD
3:20 PM
Nemolizumab long-term efficacy and safety up to 52 weeks in the OLYMPIA open- label extension study in patients with prurigo nodularis: An Interim analysis
Shawn Kwatra, MD, FAAD
3:30 PM
Efficacy and safety of topical 1% benvitimod cream for atopic dermatitis in adults and children of two years and above: A randomized, multicentre, and placebo-controlled pivotal study
Jianzhong Zhang, MD
3:40 PM
Genome-wide association study identifying genetic variants associated with atopic dermatitis in the All of Us database
Nicole Johnsen
3:50 PM
Long-Term Efficacy and Safety of SHR0302 in Patients with Moderate-to-Severe Atopic Dermatitis
Yan Zhao, MD
DIRECTOR
Hensin Tsao, MD, PhD, FAAD
SPEAKERS
Andrew F. Alexis, MPH, MD, FAAD
Andrew Blauvelt, MD, FAAD
Christopher Bunick, PhD, MD, FAAD
Robert Paul Dellavalle, MD, PhD, FAAD
Lawrence F Eichenfield, MD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Helen Y He, MD
Allison Holt
Nicole Johnsen
Sewon Kang, MD, FAAD
Brett Andrew King, MD, PhD, FAAD
Brian Kirby
Shawn Kwatra, MD, FAAD
David Latoni, MPH
Martin Metz
Paul Nghiem, MD, PhD, FAAD
Amy S. Paller, MD, FAAD
Martina J Porter, MD, FAAD
Jonathan I. Silverberg, MD, PhD, MPH, FAAD
Rodney Daniel Sinclair, MD, IFAAD
Sandy Sharon Tsao, MD, FAAD
Jill S. Waibel, MD, FAAD
Stephan Weidinger
Jianzhong Zhang, MD
Qiang Zhang
Yan Zhao, MD
HANDOUTS
DISCLOSURES
Andrew F. Alexis, MPH, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Aerolase – Other(Equipment), Speaker(Honoraria); Allergan, Inc. – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria); Alphyn Biologics – Advisory Board(Honoraria); Alumis – Advisory Board(Fees); Amgen – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Botanix Pharmaceuticals – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Dermsquared – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Eli Lilly – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Speaker(Honoraria); Elsevier Inc. – Other(Other Financial Benefit); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Genentech, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); HairDays – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte Corporation – Consultant (1099 relationship)(Fees); Janssen Scientific Affairs, LLC – Consultant(Honoraria); Johnson and Johnson – Advisory Board(Honoraria), Speaker(Honoraria); L'Oréal France – Advisory Board(Honoraria), Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Leo Pharma Inc – Consultant(Fees); Leo Pharma Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Medscape – Other(Honoraria); Novartis – Advisory Board(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Speaker(Honoraria); RBC Consultants – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Sanova Works – Speaker(Honoraria); Scientis – Speaker(Honoraria); Springer Science & Business Media – Other(Other Financial Benefit); Symrise – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Fees); UpToDate, Inc. – Other(Other Financial Benefit); VeraDermics Inc. – Advisory Board(Honoraria); Wiley-Blackwell – Other(Other Financial Benefit);
Andrew Blauvelt, MD, FAAD
AbbVie – Consultant(Honoraria); Almirall – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); AnaptysBio – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); Janssen-Ortho Inc. – Consultant(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Consultant(Honoraria); Regeneron – Consultant(Honoraria); Sanofi – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Christopher Bunick, PhD, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Advisory Boards - South Beach Symposium – Advisory Board(Fees); Almirall – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Consultant (1099 relationship)(Fees); Daiichi Sankyo – Investigator(Grants/Research Funding); Dermatology Times (MMM MultiMedia Medical, LLC) – Advisory Board(Fees); Dermsquared – Speaker/Faculty Education(Fees); Eli Lilly – Consultant (1099 relationship)(Fees); LEO Pharma, US – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); LiVDerm – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Palvella Therapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Regeneron – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Teladoc Health, Inc. – Consultant (1099 relationship)(Fees); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Robert Paul Dellavalle, MD, PhD, FAAD
American Board of Dermatology – Other(No Compensation Received); JMIR Dermatology – Other(Salary); UCB – Consultant (1099 relationship)(Honoraria); WoltersKluwer Health – Other(Patent royalties or other compensation for Intellectual Property Rights);
Lawrence F Eichenfield, MD, FAAD
Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Helen Y He, MD
CeraVe – Advisory Board(Honoraria); SkinBetter Science – Advisory Board(Honoraria);
Allison Holt
No financial relationships exist with ineligible companies.
Nicole Johnsen
No financial relationships exist with ineligible companies.
Sewon Kang, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Data Safety Monitoring Board(Fees); Rapalogix Health – Advisory Board(Stock Options); Walgreens Boots Alliance, Inc. – Investigator(Grants/Research Funding);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Brian Kirby
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Almirall – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Honoraria); Celgene – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Advisory Board(Honoraria); MC2 Therapeutics – Consultant (1099 relationship)(Honoraria); Merck & Co., Inc – Consultant (1099 relationship)(Grants/Research Funding), Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Honoraria); Novartis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
David Latoni, MPH
No financial relationships exist with ineligible companies.
Martin Metz
AbbVie – Speaker(Honoraria); Allakos – Investigator(No Compensation Received); Allegria Therapeutics – Advisory Board(Honoraria); Almirall – Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); argenx – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); AstraZeneca – Advisory Board(Honoraria); Astria Therapeutics – Advisory Board(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Bayer – Consultant (1099 relationship)(Honoraria); Berlin Chemie – Speaker(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); candid – Consultant (1099 relationship)(Honoraria); Celldex – Advisory Board(Honoraria); Celltrion – Speaker(Honoraria); Deep Apple Therapeutics – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Enanta Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Escient Pharmaceuticals, Inc – Advisory Board(Honoraria); Evommune, Inc. – Advisory Board(Honoraria); Excellergy – Consultant (1099 relationship)(Honoraria); FatiAbGen – Consultant (1099 relationship)(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Generate Biomedicines – Consultant (1099 relationship)(Honoraria); GlaxoSmithKline Immunology – Advisory Board(Honoraria); Granular Therapeutics – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); InflaRx – Consultant (1099 relationship)(Honoraria); Japan Tobacco Inc. – Consultant (1099 relationship)(Honoraria); Jasper Therapeutics – Advisory Board(Honoraria); Johnson & Johnson Pharmaceutical Research & Development – Advisory Board(Honoraria); Lycia Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Ono – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Speaker(Honoraria); RAPT Therapeutics – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria); Santa Ana Bio – Advisory Board(Honoraria); Septerna – Advisory Board(Honoraria); Tupos – Consultant (1099 relationship)(Honoraria);
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Martina J Porter, MD, FAAD
AbbVie – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding), Other(Residency/Fellowship Program Funding); Almirall – Consultant (1099 relationship)(Fees); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Avalo Therapeutics Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Bayer – Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Citryll – Advisory Board(Fees); Corvus Pharmaceuticals – Consultant (1099 relationship)(Fees); Eli Lilly – Consultant (1099 relationship)(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Insmed – Consultant (1099 relationship)(Fees); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Consultant(Fees); Merck – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Novartis – Consultant(Fees), Investigator(Grants/Research Funding); Oasis Pharmaceuticals – Investigator(Grants/Research Funding); Oruka Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Investigator(Grants/Research Funding); Propeller Bio – Consultant (1099 relationship)(Fees); Regeneron – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sonoma Biotherapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Spyre Therapeutics – Consultant (1099 relationship)(Fees); Trifecta Clinical – Consultant(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Ventyx Biosciences – Investigator(Grants/Research Funding); Zura Bio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Jonathan I. Silverberg, MD, PhD, MPH, FAAD
AbbVie – Consultant(Honoraria), Speaker(Honoraria); Aldena Therapeutics – Advisory Board(Fees); Amgen – Consultant(Fees); Apollo Therapeutics Ltd – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Fees); Attovia Therapeutics – Advisory Board(Fees); Castle Biosciences – Consultant(Fees); Connect Biopharma LLC – Consultant(Fees); Corevitas – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Galderma – Speaker(Fees); Galderma Research & Development, LLC – Consultant(Honoraria); GlaxoSmithKline – Consultant(Honoraria), Investigator(No Compensation Received); Imagene Bio – Consultant (1099 relationship)(Fees); Imagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Honoraria); Infimmune – Advisory Board(Fees); Leo Pharma Inc – Advisory Board(Honoraria); Leo Pharma Inc. – Investigator(Honoraria); Maui Derm – Speaker(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Novartis – Consultant(Fees); Organon – Speaker(Fees); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Fees); Regeneron – Consultant(Honoraria), Investigator(No Compensation Received), Speaker(Honoraria); Sanofi – Consultant(Grants/Research Funding); Sanofi Genzyme – Speaker(Honoraria); Shaperon – Consultant(Fees); UCB – Consultant (1099 relationship)(Fees); UpToDate – Other(Fees);
Rodney Daniel Sinclair, MD, IFAAD
AbbVie – Advisory Board(Fees); Aclaris Therapeutics Inc. – Investigator(Fees); Amgen – Investigator(Fees); Ascend Pharmaceuticals, Inc. – Board of Directors(Fees); Bayer – Speaker/Faculty Education(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botaneco – Investigator(Fees); Celgene Corporation – Investigator(Fees); Coherus Biosciences – Investigator(Fees); CSL – Consultant(Fees); Cutanea Life Sciences – Investigator(Fees); Eli Lilly and Company – Advisory Board(Fees); GlaxoSmithKline – Investigator(Fees); inVentiv Health – Investigator(Fees); Janssen Pharmaceuticals, Inc – Other(Fees); Johnson & Johnson Pharmaceutical Research & Development – Investigator(Fees); Leo Pharma Inc – Advisory Board(Fees); Medimmune – Investigator(Fees); Medpace – Investigator(Fees); Merck & Co., Inc – Investigator(Fees); Merck Serono – Investigator(Fees); Novartis – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Fees); PhotonMD, Inc. – Investigator(Fees); PPD Inc. – Investigator(Fees); Principia Biopharma Inc – Investigator(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Fees); Reistone Biopharma – Investigator(Fees); Revian LTD. – Investigator(Fees); Samson Clinical – Founder(Patent royalties or other compensation for Intellectual Property Rights); UCB – Investigator(Fees);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria);
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);
Stephan Weidinger
AbbVie – Advisory Board(Honoraria), Investigator(Fees); Almirall – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees); Galderma Germany – Advisory Board(Honoraria); Leo Pharma A/S – Advisory Board(Honoraria), Investigator(Fees), Other(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria);
Jianzhong Zhang, MD
No financial relationships exist with ineligible companies.
Qiang Zhang
No financial relationships exist with ineligible companies.
Yan Zhao, MD
No financial relationships exist with ineligible companies.